Clinical end points for the stroke triage studies were diverse and included: detection of large vessel occlusion (LVO), diagnosis of stroke/transient ischemic attack, tissue plasminogen activator (tPA) administration rate, stroke team activation, accurate destination triage decision, and inter-rater reliability. This evidence concerns the gene PLAT and Stroke.